Artículo

Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination

Kulkarni, Anand V.; Anders, Margarita; Nazal, Leyla; Ridruejo, EzequielIcon ; Efe, Cumali
Fecha de publicación: 02/2023
Editorial: Elsevier Science
Revista: Journal of Hepatology
ISSN: 0168-8278
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:

Resumen

Several cases of severe acute liver injury (ALI) with features of autoimmune hepatitis after SARS-CoV-2 infection or SARSCoV-2 vaccination have been described.1–7 Most cases developed ALI following mRNA or viral vector-based vaccines, while only a few reports described the development of ALI after inactivated SARS-CoV-2 vaccines.1 Recently, Wong et al.8 evaluated the risk of ALI in a large cohort of vaccine recipients. They reported that the risk of ALI did not increase due to any formulation of SARS-CoV-2 vaccination. We reviewed our cohort of patients who developed ALI after inactivated SARS-CoV-2 vaccination.
Palabras clave: COVID-19 , LIVER , SARSCOV-2 VACCINATION
 
Archivos asociados
Tamaño: 102.8Kb
Formato: PDF
.
Licencia
info:eu-repo/semantics/restrictedAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Identificadores
URI: http://hdl.handle.net/11336/228795
URL: https://www.sciencedirect.com/science/article/pii/S0168827822032834
DOI: http://dx.doi.org/10.1016/j.jhep.2022.10.026
Colecciones
Articulos(CEMIC-CONICET)
Articulos de CENTRO DE EDUCACION MEDICA E INVESTIGACIONES CLINICAS "NORBERTO QUIRNO"
Citación
Kulkarni, Anand V.; Anders, Margarita; Nazal, Leyla; Ridruejo, Ezequiel; Efe, Cumali; Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination; Elsevier Science; Journal of Hepatology; 78; 2; 2-2023; 60-61
Compartir
Altmétricas